Market revenue in 2023 | USD 21.7 million |
Market revenue in 2030 | USD 46.6 million |
Growth rate | 11.5% (CAGR from 2023 to 2030) |
Largest segment | Serum-free media |
Fastest growing segment | Serum-free Media |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH |
Serum-free media was the largest segment with a revenue share of 33.18% in 2023. Horizon Databook has segmented the South Africa cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
In South Africa, presence of organizations, such as Centre for Proteomic and Genomic Research (CPGR), is enabling availability of cell culture-based screening for a faster drug development process, which creates a demand for cell culture media. Moreover, increased interest by global players in setting up manufacturing units for vaccines in the country is expected to contribute to market growth.
For instance, in September 2021, Numolux Group and Sinovac Biotech entered into a discussion for the development of a new manufacturing facility for vaccines in South Africa for various diseases. This is anticipated to generate demand for cell culture media products in the market in the coming years.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account